The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review

BACKGROUND: It is unclear if the use of hormone therapy (HT) in carriers of BRCA mutations improves the quality of life (QOL) without increasing the risk of breast cancer following a risk-reducing salpingo-oophorectomy (RRSO). Our objective was to assess the effect of HT on QOL and breast cancer ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Siyam, Tasneem, Ross, Sue, Campbell, Sandra, Eurich, Dean T., Yuksel, Nesé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359830/
https://www.ncbi.nlm.nih.gov/pubmed/28320467
http://dx.doi.org/10.1186/s12905-017-0370-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359830/
https://www.ncbi.nlm.nih.gov/pubmed/28320467
http://dx.doi.org/10.1186/s12905-017-0370-6

Ejemplares similares